Abstract
L-carnitine was first isolated from the extracts of muscle tissue in 1905 by the employees of the department of medicinal chemistry at Moscow University. Later the role of L-carnitine in both the oxidation of long chain fatty acids and the metabolism of carbohydrates was discovered. Today L-carnitine is not just a drug for the treatment of pathologies associated with its deficiency, but also a widespread dietary supplement, believed to be able to reduce weight and improve the physical qualities of a person. However, in light of the recent findings about a possible link between L-carnitine and the development of atherosclerosis, a careful assessment of the use of L-carnitine as a safe dietary supplement is required, particularly when there is no sound medical indication.
| Translated title of the contribution | Carnitine as a Marker of Atherosclerosis and Other Risks of Cardiovascular Diseases |
|---|---|
| Original language | Russian |
| Pages (from-to) | 91-96 |
| Number of pages | 6 |
| Journal | Kardiologiya |
| Volume | 54 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 2014 |
| Externally published | Yes |
Keywords*
- Atherosclerosis
- Cardiovascular diseases
- L-carnitine
- Marker
- Meldonium
Field of Science*
- 3.1 Basic medicine
Publication Type*
- 1.1. Scientific article indexed in Web of Science and/or Scopus database
